MCRB SERES THERAPEUTICS INC Management Changes 8-K Filing 2025 - Board Appointment Seres Therapeutics appointed Dr. Hans-Juergen Woerle as a new director, increasing the board size to nine, with a compensation package including an annual retainer of $45,000 and an option to purchase 120,000 shares at $0.8056 each.Get access to all SEC 8-K filings of the SERES THERAPEUTICS INC